Bivalent non-human gal-α1-3-gal glycan epitopes in the Fc region of a monoclonal antibody model can be recognized by anti-Gal-α1-3-Gal IgE antibodies
Monoclonal antibody (mAb) production using non-human cells can introduce non-human glycan epitopes including terminal galactosyl-α1–3-galactose (α1–3-Gal) moieties. Cetuximab is a commercial mAb associated with causing anaphylaxis in some patients due to the binding of endogenous anti-α1–3-Gal IgE t...
Saved in:
| Main Authors: | Grayson Hatfield, Lioudmila Tepliakova, Jessica Tran, Huixin Lu, Michel Gilbert, Roger Y. Tam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | mAbs |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2239405 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acceleration of Wound Healing by α-gal Nanoparticles Interacting with the Natural Anti-Gal Antibody
by: Uri Galili
Published: (2015-01-01) -
Conversion of Tumors into Autologous Vaccines by Intratumoral Injection of α-Gal Glycolipids that Induce Anti-Gal/α-Gal Epitope Interaction
by: Uri Galili
Published: (2011-01-01) -
Precision Probing of O-GalNAc Glycosylation Using Bump-and-Hole Engineering
by: Abdul Zafar, et al.
Published: (2025-03-01) -
Involvement of ST6Gal I‐mediated α2,6 sialylation in myoblast proliferation and differentiation
by: Caroline Vergé, et al.
Published: (2020-01-01) -
IgG to Galactose-Alpha-1,3-Galactose: Impact of Alpha-Gal IgE Sensitization, Blood Type, and Tick Bites
by: Samuel M. Ailsworth, et al.
Published: (2025-05-01)